Ameriprise Financial Inc Edwards Lifesciences Corp Transaction History

Ameriprise Financial Inc

$364 Billion
Q2 2024

A detailed history of Ameriprise Financial Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 3,202,730 shares of EW stock, worth $210 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,202,730

Previous 2,454,959 30.46%

Holding current value

$210 Million

Previous $235 Million 26.1%

% of portfolio

0.08%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $63 Million - $70.5 Million	747,771 Added 30.46%	3,202,730 $296 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $46 Million - $60.6 Million	633,858 Added 34.81%	2,454,959 $235 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $8.41 Million - $10.6 Million	136,290 Added 8.09%	1,821,101 $139 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $29 Million - $39.1 Million	-418,967 Reduced 19.91%	1,684,811 $117 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $7.83 Million - $9.07 Million	-96,130 Reduced 4.37%	2,103,778 $198 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $1.57 Million - $1.78 Million	21,090 Added 0.97%	2,199,908 $182 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $84.5 Million - $108 Million	-1,237,435 Reduced 36.22%	2,178,818 $163 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $35.2 Million - $45.8 Million	-426,967 Reduced 11.11%	3,416,253 $283 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $75.5 Million - $112 Million	873,155 Added 29.4%	3,843,220 $365 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $21.9 Million - $27.5 Million	214,484 Added 7.78%	2,970,065 $348 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $58.6 Million - $72 Million	-551,182 Reduced 16.67%	2,755,581 $355 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $181 Million - $216 Million	-1,757,652 Reduced 34.71%	3,306,763 $374 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $2.81 Million - $3.51 Million	33,525 Added 0.67%	5,064,415 $524 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $109 Million - $125 Million	1,381,907 Added 37.87%	5,030,890 $421 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $12.5 Million - $15.9 Million	-174,265 Reduced 4.56%	3,648,983 $333 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $5.29 Million - $6.89 Million	-78,747 Reduced 2.02%	3,823,248 $305 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $158 Million - $211 Million	2,740,924 Added 236.07%	3,901,995 $270 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $19.4 Million - $29.9 Million	-369,643 Reduced 24.15%	1,161,071 $219 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $10.9 Million - $12.5 Million	-151,811 Reduced 9.02%	1,530,714 $357 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $12 Million - $14.7 Million	-194,955 Reduced 10.38%	1,682,525 $370 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $2.15 Million - $2.48 Million	-38,559 Reduced 2.01%	1,877,480 $347 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $12.9 Million - $17.2 Million	-269,112 Reduced 12.32%	1,916,039 $367 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $2.68 Million - $3.29 Million	-57,726 Reduced 2.57%	2,185,151 $334 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $4.24 Million - $5.39 Million	-92,874 Reduced 3.98%	2,242,877 $390 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $24.4 Million - $29.5 Million	-575,355 Reduced 19.76%	2,335,751 $340 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $32.9 Million - $42 Million	-884,260 Reduced 23.3%	2,911,106 $406 Million
Q4 2017 Feb 12, 2018	SELL	$33.79 - $39.39 $14.7 Million - $17.2 Million	-436,109 Reduced 10.31%	3,795,366 $428 Million
Q3 2017 Nov 07, 2017	BUY	$36.29 - $38.83 $154 Million - $164 Million	4,231,475	4,231,475 $463 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Edwards Lifesciences Corp Transaction History